Vontobel Holding Ltd. Has $409,000 Position in Certara, Inc. (NASDAQ:CERT)

Vontobel Holding Ltd. lowered its position in Certara, Inc. (NASDAQ:CERT) by 16.7% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 23,264 shares of the company’s stock after selling 4,657 shares during the period. Vontobel Holding Ltd.’s holdings in Certara were worth $409,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Envestnet Asset Management Inc. increased its holdings in Certara by 45.3% in the third quarter. Envestnet Asset Management Inc. now owns 335,440 shares of the company’s stock worth $4,877,000 after buying an additional 104,616 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in Certara by 5.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 607,030 shares of the company’s stock worth $8,826,000 after buying an additional 32,790 shares during the last quarter. Kayne Anderson Rudnick Investment Management LLC boosted its position in Certara by 48.8% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 727,240 shares of the company’s stock worth $10,574,000 after purchasing an additional 238,603 shares during the period. State of New Jersey Common Pension Fund D boosted its position in Certara by 31.6% during the third quarter. State of New Jersey Common Pension Fund D now owns 151,785 shares of the company’s stock worth $2,207,000 after purchasing an additional 36,490 shares during the period. Finally, William Blair Investment Management LLC boosted its position in Certara by 1.1% during the third quarter. William Blair Investment Management LLC now owns 7,150,914 shares of the company’s stock worth $103,974,000 after purchasing an additional 77,805 shares during the period. Institutional investors and hedge funds own 73.96% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on CERT. Barclays upped their target price on Certara from $16.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Thursday, January 25th. SVB Leerink began coverage on Certara in a research report on Monday, February 26th. They set a “market perform” rating and a $19.00 target price for the company. KeyCorp raised Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 target price for the company in a research report on Wednesday, April 10th. Jefferies Financial Group upped their target price on Certara from $14.00 to $15.50 and gave the stock a “hold” rating in a research report on Friday, March 1st. Finally, Leerink Partnrs reaffirmed a “market perform” rating on shares of Certara in a research report on Monday, February 26th. Seven analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, Certara has a consensus rating of “Hold” and a consensus price target of $20.06.

Insiders Place Their Bets

In other Certara news, SVP Richard M. Traynor sold 3,000 shares of Certara stock in a transaction on Monday, April 1st. The shares were sold at an average price of $18.00, for a total transaction of $54,000.00. Following the sale, the senior vice president now owns 173,524 shares in the company, valued at $3,123,432. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other Certara news, SVP Richard M. Traynor sold 3,000 shares of Certara stock in a transaction on Monday, April 1st. The shares were sold at an average price of $18.00, for a total transaction of $54,000.00. Following the sale, the senior vice president now owns 173,524 shares in the company, valued at $3,123,432. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Richard M. Traynor sold 6,000 shares of Certara stock in a transaction on Monday, February 12th. The stock was sold at an average price of $18.00, for a total transaction of $108,000.00. Following the sale, the senior vice president now owns 165,368 shares in the company, valued at approximately $2,976,624. The disclosure for this sale can be found here. Insiders have sold 23,427 shares of company stock worth $405,095 over the last 90 days. Corporate insiders own 2.60% of the company’s stock.

Certara Trading Up 3.5 %

Shares of Certara stock opened at $16.73 on Wednesday. The company’s fifty day simple moving average is $17.78 and its 200-day simple moving average is $16.22. The company has a market cap of $2.68 billion, a price-to-earnings ratio of -47.80, a PEG ratio of 1.64 and a beta of 1.63. The company has a current ratio of 2.62, a quick ratio of 2.62 and a debt-to-equity ratio of 0.28. Certara, Inc. has a 1 year low of $11.81 and a 1 year high of $24.70.

Certara (NASDAQ:CERT) last announced its quarterly earnings data on Thursday, February 29th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.04). The company had revenue of $88.01 million during the quarter, compared to analyst estimates of $86.80 million. Certara had a positive return on equity of 4.33% and a negative net margin of 15.62%. As a group, sell-side analysts expect that Certara, Inc. will post 0.29 EPS for the current year.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.